Jiangsu Sihuan Bioengineering Co., Ltd
SHZ: 000518.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yu Guo
- Employees
- 282
- Headquarters
- Jiangyin, China
- IPO year
- 1993
- Market cap
- CN¥3.2B
- Website
- https://www.000518shsw.com/shsw
Loading 000518…
Loading profile data…Frequently asked questions about 000518
What does Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ) do?
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers Drewson, an anti-tumor biotherapeutic drug for the treatment of renal cancer, malignant melanoma, and cancerous thoracic and peritoneal effusion; and Xinde Lusheng for the treatment of kidney cancer, melanoma, lung cancer, gastric cancer, malignant...
Where does 000518.SZ trade?
Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ) trades on the Shenzhen Stock Exchange.
What sector is 000518.SZ in?
Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Jiangsu Sihuan Bioengineering Co., Ltd?
Yu Guo is the chief executive officer of Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ).
Where is Jiangsu Sihuan Bioengineering Co., Ltd headquartered?
Jiangsu Sihuan Bioengineering Co., Ltd is headquartered in China.
Does 000518.SZ pay a dividend?
Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 000518.SZ go public?
Jiangsu Sihuan Bioengineering Co., Ltd (000518.SZ) completed its initial public offering in 1993.